SHANGHAI, July 31,
2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or
the "Company"), a leading tech-enabled healthcare platform company
committed to digitally connecting patients with medicine and
healthcare services in China, today announced that it will
report its unaudited financial results for the second quarter
ended June 30, 2023, before the U.S. market opens
on Thursday, August 24, 2023.
111's management team will host an earnings conference call
at 7:30 AM U.S. Eastern Time on Thursday, August 24,
2023 (7:30 PM Beijing Time on the same day).
Details for the conference call are as follows:
Conference Topic: 111, Inc. Second Quarter 2023 Earnings
Conference Call
Registration
Link: https://s1.c-conf.com/diamondpass/10032701-ygfhis.html
All participants must use the link provided above to complete
the online registration process in advance of the conference call.
Upon registering, each participant will receive a set of
participant dial-in numbers, the Direct Event passcode, and a
unique Registration ID, which can be used to join the conference
call.
Please dial in 15 minutes before the call is scheduled to begin
and provide the Direct Event passcode and unique Registration ID
you have received upon registering to join the call.
A telephone replay of the call will be available after the
conclusion of the conference call until August 31, 2023
United States: +1 855 883
1031
Mainland China: 4001 209 216
Hong Kong: 800 930 639
International: +61 7 3107 6325
Conference ID: 10032701
A live and archived webcast of the conference call will be
available on the website at
https://edge.media-server.com/mmc/p/iw7ck9oc
About 111, Inc.
111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading
tech-enabled healthcare platform company committed to digitally
connecting patients with medicine and healthcare services
in China. The Company provides consumers with better access to
pharmaceutical products and healthcare services directly through
its online retail pharmacy, 1 Pharmacy, and indirectly through its
offline virtual pharmacy network. The Company also offers online
healthcare services through its internet hospital, 1 Clinic, which
provides consumers with cost-effective and convenient online
consultation, electronic prescription service, and patient
management service. In addition, the Company's online platform, 1
Medicine Marketplace, serves as a one-stop shop for pharmacies to
source a vast selection of pharmaceutical products. With the
largest virtual pharmacy network in China, 111 enables offline
pharmacies to better serve their customers with cloud-based
services. 111 also provides an omni-channel drug commercialization
platform to its strategic partners, which includes services such as
digital marketing, patient education, data analytics, and pricing
monitoring.
For more information on 111, please
visit: http://ir.111.com.cn/.
View original
content:https://www.prnewswire.com/news-releases/111-to-announce-second-quarter-2023-unaudited-financial-results-on-august-24-2023---conference-call-to-follow-301889101.html
SOURCE 111, Inc.